Zoetis Inc (ZTS) concluded trading on Thursday at a closing price of $160.35, with 3.54 million shares of worth about $567.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.97% during that period and on May 15, 2025 the price saw a gain of about 3.51%. Currently the company’s common shares owned by public are about 446.04M shares, out of which, 441.03M shares are available for trading.
Stock saw a price change of -0.83% in past 5 days and over the past one month there was a price change of 7.46%. Year-to-date (YTD), ZTS shares are showing a performance of -1.58% which decreased to -4.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $139.70 but also hit the highest price of $200.33 during that period. The average intraday trading volume for Zoetis Inc shares is 3.08 million. The stock is currently trading 3.35% above its 20-day simple moving average (SMA20), while that difference is up 1.66% for SMA50 and it goes to -7.27% lower than SMA200.
Zoetis Inc (NYSE: ZTS) currently have 446.04M outstanding shares and institutions hold larger chunk of about 97.05% of that.
The stock has a current market capitalization of $71.39B and its 3Y-monthly beta is at 0.91. PE ratio of stock for trailing 12 months is 28.79, while it has posted earnings per share of $5.57 in the same period. Its PEG reads 3.40 and has Quick Ratio of 1.04 while making debt-to-equity ratio of 1.45. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZTS, volatility over the week remained 2.66% while standing at 2.82% over the month.
Stock’s fiscal year EPS is expected to rise by 5.05% while it is estimated to increase by 10.11% in next year. EPS is likely to shrink at an annualized rate of 8.46% for next 5-years, compared to annual growth of 11.91% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Leerink Partners on December 02, 2024 offering an Outperform rating for the stock and assigned a target price of $215 to it. Coverage by BTIG Research stated Zoetis Inc (ZTS) stock as a Buy in their note to investors on July 25, 2024, suggesting a price target of $220 for the stock. On January 12, 2024, Stifel Reiterated their recommendations, while on December 19, 2023, Jefferies Resumed their ratings for the stock with a price target of $230. Stock get an Outperform rating from Exane BNP Paribas on December 07, 2023.
